The Association Between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Clinical Presentation of Coronary Artery Disease in Patients Underwent Percutaneous Coronary Intervention

The Association Between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Clinical Presentation of Coronary Artery Disease in Patients Underwent Percutaneous Coronary Intervention - The Association Between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Clinical Presentation of Coronary Artery Disease in Patients Underwent Percutaneous Coronary Intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023461

Enrollment

500

Registered

2016-08-03

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were measured of fatty acids profiles at the time of PCI.

Exclusion criteria

Exclusion criteria: Patients who already received EPA supplementation at the time of PCI.

Design outcomes

Primary

Measure	Time frame
Type of coronary artery disease and EPA/AA ratio	—

Countries

Japan

Contacts

Public ContactKentaro Jujo

Nishiarai Heart Center Hospital Cardiology

juken1123@hotmail.co.jp+81358380730

Outcome results